Community Health Worker Program

The ICD is engaged in the Delaware Academy of Medicine/Delaware Public Health Association’s COVID-19 Community Health Worker (CHW) Initiative. This initiative aims to address persistent health disparities and vaccine hesitancy in Pennsylvania and Delaware by offering support and resources to vulnerable and under-resourced populations, and to newly identified populations eligible to receive the COVID-19 vaccine. Read more

DJPH: Vaccine Preventable Disease

The latest issue of the Delaware Journal of Public Health focuses on Vaccine Preventable Disease. Guest Editors Omar Khan, MD, MHS and Stephen Eppes, MD have curated content about current vaccine recommendations, travel vaccines, vaccines specific to certain viruses, vaccine hesitancy, and vaccination exemptions.  The journal is open-source, and free to all.  Check it out here

MOTIVATE Project

The Motivating Older Adults to Trust Information About Vaccines and Their Effects (MOTIVATE) project is a partnership between Center in the Park and Rutgers University that focuses on vaccine hesitancy among older adults. Led by peer leaders and pharmacists, it addresses vaccine education for COVID-19, Pneumonia, and Flu. This two session project will be conducted via zoom and participants will receive a $10 Visa gift card for participation. For more information, contact Keyerra Charles, Director of Health Promotion at 215-848-7722 Ext 305 or email kcharles@centerinthepark.org

My Vaccine Counts

To address issues of vaccine education and outreach in Delaware and Pennsylvania, the Delaware Academy of Medicine/Delaware Public Health Association and the Public Health Management Corporation are implementing a comprehensive and integrated approach designed to target, engage, and connect individuals to COVID-19 vaccines and information. The central component to this model is community health workers (CHWs). These public health and social service professionals support the members of their community by helping them to adopt healthy behaviors including staying up to date on all vaccinations. The model identifies, engages, trains, and supports CHWs from communities across the two states to help Read More …

DPH to Implement Updated CDC Guidance Reducing Isolation, Quarantine Periods

DOVER, DE (Dec. 28, 2021) – The Division of Public Health announced that it will implement updated guidance issued Monday by the Centers for Disease Control and Prevention (CDC) to shorten the recommended time that people should isolate or quarantine from 10 days to 5 days based on certain conditions and vaccination status.  The change is motivated by science demonstrating that the majority of COVID-19 transmission occurs early in the course of illness, generally in the 1-2 days prior to onset of symptoms and the 2-3 days after. Therefore, people who test positive should isolate for 5 days and, if they have no Read More …

DPH Advises Vaccine Providers to Offer Pfizer COVID-19 Vaccine for Children 5-11 Years of Age

DOVER (NOV. 3, 2021) – The Delaware Division of Public Health (DPH) today announced that Delaware’s vaccine providers can begin administering the Pfizer-BioNTech COVID-19 pediatric vaccine to children ages 5 to 11. Today’s announcement comes after the U.S. Food and Drug Administration (FDA) last week gave its approval to expand Emergency Use Authorization (EUA) to allow for the Pfizer vaccine to be administered to children in this age group. The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) met Tuesday and agreed with the FDA findings. CDC Director Dr. Rochelle P. Walensky endorsed the advisory Read More …

DPH Advises Vaccine Providers to Offer Pfizer Booster to Eligible Delawareans

PRIORITY TO Seniors, lONG-TERM CARE RESIDENTS AND THOSE AT RISK of severe COVID-19  DOVER (SEPT. 24, 2021) – The Delaware Division of Public Health (DPH) today announced that the state’s vaccine providers can begin administering booster doses of the Pfizer-BioNTech vaccine to certain populations recommended by the Centers for Disease Control and Prevention (CDC). On Wednesday, the U.S. Food and Drug Administration (FDA) formally voted to expand the Emergency Use Authorization (EUA) to allow for a booster dose of Pfizer-BioNTech vaccine to be administered for certain populations six months after receiving the second dose of the Pfizer vaccine. Boosters are Read More …

FDA Fully Licenses Pfizer-BioNTech’s COVID-19 Vaccine

Today, the U.S. Food and Drug Administration (FDA) fully licensed Pfizer-BioNTech’s COVID-19 vaccine – now named “Comirnaty” – for those 16 years of age and older. The agency first authorized the vaccine for emergency use in this age group in December after clinical trials showed it was safe and effective for at least two months. Now that researchers have the safety and efficacy data of approximately 44,000 people from the clinical trials, the FDA has confirmed that the benefits of the vaccine greatly outweigh the risks. The mRNA vaccine has cleared the benchmarks for licensure the FDA set last year Read More …

Governor Carney Announces Mask Requirement in K-12 Schools

WILMINGTON, Del. – Governor John Carney on Tuesday announced that everyone kindergarten-age and older in K-12 schools and child care homes and centers must wear face coverings indoors effective on Monday, August 16 – regardless of vaccination status. The requirement covers both public and private schools in Delaware. Child care centers and homes are strongly encouraged to require masks for children 2 years old to kindergarten inside their facilities to prevent spread of COVID-19. Children younger than 2 years old should not wear masks due to risk of suffocation.  The statewide mask requirement in schools, which will be formalized later this week, is consistent with guidance from Read More …

Updated COVID-19 Recommendations

Dover (Aug. 3, 2020) – Governor John Carney, the Delaware Division of Public Health (DPH), and the Delaware Emergency Management Agency (DEMA) are providing updates to Delaware’s COVID-19 testing program. COVID-19 vaccines are effective against severe disease and death from variants of the virus that causes COVID-19 currently circulating in the United States, including the Delta variant. Infections happen in only a small proportion of people who are fully vaccinated, even with the Delta variant. When these infections occur among vaccinated people, they tend to be mild. With COVID-19 cases increasing in the state and nation, and the majority of Read More …